
This Week in Virology TWiV 1218: Clinical update with Dr. Daniel Griffin
May 17, 2025
Join infectious disease specialist Dr. Daniel Griffin as he dives into pressing public health challenges. He discusses the disturbing cancellation of CDC committees and rising mpox cases in Sierra Leone. Dr. Griffin also sheds light on the ongoing measles outbreaks and the importance of vaccination amid these crises. Unpacking insights from wastewater analysis, he emphasizes its role in tracking COVID-19. He also explores the connection between long COVID, obesity, and emerging treatment options like remdesivir, pushing for advocacy in health policy.
AI Snips
Chapters
Transcript
Episode notes
Severe Pediatric Flu Impact
- The 2024-25 flu season was severe with over 226 pediatric deaths, mostly unvaccinated children.
- Many children died quickly from influenza despite appearing otherwise healthy prior to infection.
Biloxiivir Use in Infants
- Biloxiivir antiviral treatment is safe and effective for children under one year with influenza.
- Early administration reduces fever duration and viral shedding, crucial for infant flu management.
RSV Prevention Success
- Introduction of maternal RSV vaccines and long-acting monoclonal antibodies has significantly reduced infant RSV hospitalizations.
- The largest benefits were observed in newborns between zero and two months of age.

